Catalytic antibodies: hapten design strategies and screening methods

Bioorganic & Medicinal Chemistry
Yang XuK D Janda

Abstract

Catalytic antibodies have emerged as powerful tools for the efficient and specific catalysis of a wide range of chemical transformations. Generating antibody catalysts that achieve enzymatic efficiency remains a challenging task, which has long been the source of great interest both in the design of more effective haptens for immunization and in the development of more direct and efficient screening methods for the selection of antibodies with desired catalytic capacities. In this review, we describe the development of different hapten design strategies, including a transition state analog (TSA) approach, 'bait-and-switch' catalysis, and reactive immunization. We also comment on recent developments in the screening process that allow for a more efficient identification of antibody catalysts.

References

Nov 1, 1975·Journal of Dental Research·L E RossmanP Robinson
Aug 17, 1990·Science·A G Cochran, P G Schultz
Oct 15, 1988·Cancer·S Silverman
Dec 19, 1986·Science·S J PollackP G Schultz
Jan 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D S TawfikZ Eshhar
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·J D StewartS J Benkovic
May 27, 1994·Science·T LiR A Lerner
Jan 21, 1994·Journal of Molecular Biology·V A RobertsE D Getzoff
Jan 22, 1993·Science·K D JandaR A Lerner
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·H D UlrichP G Schultz
Dec 15, 1995·Science·P WirschingR A Lerner
Feb 23, 1996·Science·P A PattenP G Schultz
Jun 1, 1996·Chemistry & Biology·G MacBeath, D Hilvert
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·P WentworthK D Janda
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·B ListR A Lerner
Aug 10, 1999·Journal of Molecular Biology·M M ThayerV A Roberts
Mar 4, 2000·The Biochemical Journal·O GonçalvesC Tellier
May 29, 2000·Applied Biochemistry and Biotechnology·A TramontanoS Paul
Aug 31, 2000·Annual Review of Biochemistry·D Hilvert
Feb 24, 2001·Bioorganic & Medicinal Chemistry Letters·M MatsushitaK D Janda
Oct 24, 2001·Inorganic Chemistry·Akira HaradaMikiharu Kamachi
May 16, 1997·The Journal of Organic Chemistry·Josef SchröerJean-Louis A. Reymond
Oct 26, 2001·Bioorganic & Medicinal Chemistry Letters·F TanakaC F Barbas
Jan 5, 2002·Chemistry : a European Journal·N BenselJ L Reymond
Mar 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kenneth M NicholasKim D Janda
Apr 4, 2002·Journal of the American Chemical Society·Fujie Tanaka, Carlos F Barbas

❮ Previous
Next ❯

Citations

Dec 20, 2012·Applied Microbiology and Biotechnology·Raouia Ben NayaSéverine Padiolleau-Lefèvre
Jul 22, 2009·Nature Chemical Biology·Steven D Schwartz, Vern L Schramm
Sep 6, 2012·Organic & Biomolecular Chemistry·Thanit PraneenararatHelen E Blackwell
Nov 28, 2008·Assay and Drug Development Technologies·Andrew D Napper
Dec 15, 2012·PloS One·Victor Muñoz RoblesBéatrice Golinelli-Pimpaneau
Feb 17, 2011·Immunotherapy·Carima AndradyKerry A Chester
Mar 22, 2014·Biotechnology Letters·Séverine Padiolleau-LefèvreBérangère Avalle
May 21, 2010·Trends in Biotechnology·Misha V Golynskiy, Burckhard Seelig
Apr 3, 2007·Journal of Molecular Biology·Erik W DeblerIan A Wilson
Sep 22, 2005·Proteins·Vesa P HytönenMarkku S Kulomaa
Jul 3, 2009·Biotechnology Progress·Srinath KasturiranganMichael Sierks
Nov 29, 2014·Wiley Interdisciplinary Reviews. Computational Molecular Science·Orlando Acevedo, Wiliiam L Jorgensen
Nov 18, 2005·Immunology Letters·Sudhir PaulHiroaki Taguchi
Jan 1, 2012·Computational and Structural Biotechnology Journal·Manish Kumar TiwariJung-Kul Lee
Feb 14, 2012·Molecular Immunology·Damien Le MinouxSéverine Padiolleau-Lefèvre
Jun 29, 2010·Journal of Physical Organic Chemistry·Sara Quaytman MachlederSteven D Schwartz
Nov 1, 2005·Expert Review of Clinical Immunology·Kerry A ChesterAstrid Mayer
Mar 14, 2009·Chemical Communications : Chem Comm·Prashant B KapadnisDavid R Spring
Sep 14, 2012·Chemical Society Reviews·Zeyuan DongJunqiu Liu
Mar 26, 2013·Angewandte Chemie·Gert KissK N Houk
Sep 12, 2015·Chembiochem : a European Journal of Chemical Biology·Michio SatoKenji Watanabe
Aug 28, 2020·Chembiochem : a European Journal of Chemical Biology·Wadih GhattasA Jalila Simaan
Nov 10, 2005·Chemical Reviews·John W Kehoe, Brian K Kay
Apr 11, 2020·Trends in Immunology·Jordan D Dimitrov, Sébastien Lacroix-Desmazes
Jul 14, 2021·ACS Chemical Neuroscience·Mingliang LinKim D Janda
Feb 28, 2013·The Journal of Physical Chemistry. a·Jean E Masterson, Steven D Schwartz
Jan 24, 2012·The Journal of Physical Chemistry. B·Cameron C WeberThomas Maschmeyer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cell Biochemistry and Biophysics
P Wentworth, K D Janda
BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology
Alexey BelogurovA G Gabibov
Current Opinion in Biotechnology
Carl HansonSudhir Paul
© 2021 Meta ULC. All rights reserved